Near-Infrared Light Therapy After Stroke: Does the Science Hold Up?Near-Infrared Light Therapy After Stroke: Does the Science Hold Up?
Recovery After Stroke
Bill Gasiamis breaks down the science behind near-infrared light therapy after stroke, separating realistic hope from marketing hype. He explains the biological basis, current research, and why proven rehabilitation should stay front and centre in recovery.
7:13•1 May 2026
Near-Infrared Light Helmets After Stroke: Hype, Hope, or Helpful?
Episode Overview
- Near-infrared light therapy has a real biological mechanism, involving mitochondrial enzymes and increased cellular energy.
- Early human studies show encouraging signals, but there are no completed phase 3 trials and evidence is still limited.
- Devices used in research are not the same as consumer helmets and caps sold online, differing in power, precision, and protocols.
- The main risk is wasting money and attention on unproven devices and neglecting proven stroke rehabilitation methods.
- A practical approach is to follow ongoing research, check genuine clinical trials, and never replace effective therapy with experimental tools.
“The mechanism, real. The early results, encouraging. The safety, looks good so far. But we're not there yet.”
How do people rebuild their brains after a stroke using something as simple as light? This episode of **Recovery After Stroke** takes on that exact question, with Bill Gasiamis breaking down near-infrared light therapy in plain, no-nonsense language. A viewer asks about those shiny near-infrared helmets that promise brain recovery after stroke. Instead of hype, you’ll get a careful walk-through of what the science actually says.
Bill explains that near-infrared light, in the 600–1000 nanometre range, can pass through the scalp and skull and be absorbed by "cytochrome c oxidase," a key enzyme in mitochondria. That matters because it’s linked to more ATP – more energy – for struggling brain cells after stroke. He also talks through the extra effects researchers are watching: improved blood flow, reduced inflammation, and changes connected to neuroplasticity.
Bill references recent reviews that describe the approach as a “promising multi-targeted approach for protecting and restoring brain function”, while stressing that human studies are still early and there are **no completed phase 3 trials yet**. The tone stays grounded and protective of stroke survivors.
Bill is crystal clear that "the claims being made by some of these products are way ahead of the actual evidence" and that the real risk is wasting money and attention on unproven devices instead of proven rehab tools and therapy. He reminds people that devices used in clinical trials are not the same as the consumer gadgets sold online.
By the end, you’ll have a simple roadmap: watch the research, look up real clinical trials if you’re curious, and never swap out effective rehab for something experimental. It’s science, scepticism, and encouragement all rolled into one. It might even help you ask a much sharper question at your next medical appointment.

Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.
